Skip to main content

Goldsmith George Jay's Form 4 filing

COMPASS Pathways plc (CMPS) · filed Oct 25, 2024

Accession no.
0001816590-24-000125
Filed
Oct 25, 2024
Trade date
Oct 24, 2024
Filing delay
1 day
Rule 10b5-1 plan
Not checked

This filing lists 2 non-derivative transactions. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Goldsmith George JayCIK 000184385910% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Oct 24, 2024Ordinary SharesSSaleDisposed−776,565–F2–3,155,122Direct
Oct 24, 2024Ordinary SharesSSaleDisposed−776,565–F2–3,152,848Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The transaction is a private sale of American Depositary Shares (ADSs) to Lars Wilde, a former co-founder of Compass Pathways plc (the "Company"), pursuant to the terms of previously disclosed call option agreements dated May 19, 2020, as amended and restated on July 21, 2020, as further amended and restated on September 9, 2020, and as further amended effective February 15, 2023 by and among the Company and Mr. Wilde and each of Mr. Goldsmith and Dr. Malievskaia. Pursuant to the terms of such agreements, Mr. Wilde had an option to purchase 776,565 of ADSs for the nominal value per ordinary share, from each of Mr. Goldsmith and Dr. Malievskaia, exercisable at any time following our initial public offering until September 9, 2033. On October 24, 2024, Mr. Wilde delivered irrevocable exercise notices to purchase 776,565 from each of Mr. Goldsmith and Dr. Malievskaia.

Referenced by the price of 2 transactions in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)